33:
779:
223:
In 2022, Zhavoronkov participated in a round of financing for
Insilico Medicine that raised $ 60 million for the venture. Zhavoronkov asserted at the time that the industry was "in 'biotechnology winter' where many companies are running out of cash and are dying", and that his fundraising was
212:
were early investors in
Zhavoronkov's efforts. Robbins wrote of Zhavoronkov that "researchers had been using GANs to do things like design new objects or create one-of-a-kind, fake human faces, but Zhavoronkov wanted to apply them to pharmacology".
672:
261:
technology that evaluate people's external appearance through certain algorithms. In this role, he responded to concerns about ethnic bias in results generated by the platform by attributing them to a lack of data provided to it.
1086:
151:, and as of 2024, was also the director of the Biogerontology Research Foundation, a UK-based think-tank for aging research. Zhavoronkov has published a substantial number of papers, and books including
245:
In June 2023, Zhavoronkov led
Insilico's development of what he described as "the first fully generative AI drug to reach human clinical trials, and specifically Phase II trials with patients".
204:
In 2014, Zhavoronkov began work towards using "massive data sets and Al to significantly speed up the drug discovery process", and established
Insilico at Johns Hopkins University in Baltimore.
676:
273:
as a coauthor. Zhavoronkov reported that when he asked ChatGPT itself whether it should be named as a coauthor, "it responded with multiple compelling reasons as to why it should not".
716:
378:
371:
Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal chemist in virtual reality
1111:
931:
513:
462:
196:. Zhavoronkov was named as a co-inventor on a patent issued in May 2013 for "systems and methods for communicating with a computer using brain activity patterns".
777:, Alex Zavoronkov, Mikhail Bakhnyan, "Systems and methods for communicating with a computer using brain activity patterns", issued May 14, 2013
238:, sharply criticized comments by Zhavoronkov, who had observed that organ transplants used to facilitate life extension could someday be provided by using
916:
1239:
623:
431:
1128:
518:
189:
1229:
1052:
1031:
292:
Since 2010, Zhavoronkov has authored or co-authored over 250 scientific articles published in refereed journals and referenced in
1234:
1010:
577:
986:
228:
described
Zhavoronkov at the time as well-known within the longevity community "for his relentless focus". In February 2023,
603:
193:
734:
968:
894:
693:
616:
877:
354:
331:
917:"GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market"
173:
63:
32:
1249:
1193:
1153:
649:
949:
396:
P. Mamoshina, A. Vieira, E. Putin, A. Zhavoronkov (2016). "Applications of deep learning in biomedicine".
774:
276:
In May 2024, Zhavoronkov was noted to have funded production of a realistically animated rendition of a
1244:
867:
181:
67:
969:"This Biotech Company Wants You to Give it Selfies and Blood Tests in Exchange for Cryptocurrency"
752:
486:
258:
185:
105:
673:"The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy (review)"
1224:
346:
280:, with the face of the transplant subject being recognized as Zhavoronkov's own. This became a
180:
before moving to the biotechnology field. He received a master's degree in biotechnology from
1199:
425:
144:
97:
1140:
269:, which was described as one of the first peer-reviewed published papers to formally credit
806:
624:"Biogerontology Research Foundation Salutes Staff On Multi-Year Drug Development Agreement"
216:
In
November 2017, Zhavoronkov proposed the application of the deep learning techniques and
38:
267:
Rapamycin in the context of Pascal's Wager: generative pre-trained transformer perspective
8:
177:
810:
829:
794:
558:
409:
899:
873:
834:
562:
550:
413:
350:
327:
324:
The
Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy
311:
153:
The
Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy
148:
115:
78:
The
Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy
1112:"That viral video showing a head transplant is a fake. But it might be real someday"
385:
1092:
1081:
824:
814:
654:
581:
542:
405:
101:
793:
Bobrov, P; Frolov, A; Cantor, C; Fedulova, I; Bakhnyan, M; Zhavoronkov, A (2011).
1015:
1006:
863:
819:
608:
491:
467:
395:
277:
234:
229:
209:
932:"Skolkovo scientist says AI and blockchain could accelerate biomedical research"
578:"Big investors pour funds into longevity research, accelerating growth in field"
1188:
1087:
Proceedings of the
National Academy of Sciences of the United States of America
1032:"The first fully A.I.-generated drug enters clinical trials in human patients"
370:
1218:
1194:
CBS Radio interview of Alexander Zhavoronkov with Dan Raviv in Washington, DC
239:
140:
1096:
192:. As of 2024, he was an adjunct professor of artificial intelligence at the
859:
838:
554:
417:
386:
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
205:
533:
Eric Smaley (2017). "AI-powered drug discovery captures pharma interest".
487:"Biotech begins human trials of drug designed by artificial intelligence"
458:
281:
225:
721:
Pharmaceutical Journal, the Journal of the Royal Pharmacological Society
546:
1204:
991:
717:"Artificial Intelligence: will it change the way drugs are discovered?"
514:"Alex Zhavoronkov Aims to Take Over the Drug Development World with AI"
315:
217:
254:
1167:
343:
Dating A.I.: A guide to falling in love with Artificial Intelligence
987:"Hong Kong's AI drug discovery firm Insilico closes $ 60M Series D"
950:"Bitcoin Tech Lets People Reclaim Their Data, Says Medical Startup"
735:"News: Neural network learns to select potential anticancer drugs"
1053:"Why An AI-Judged Beauty Contest Picked Nearly All White Winners"
270:
224:
positioning the company for a coming "biotech spring". AI writer
795:"Brain-computer interface based on generation of visual images"
293:
169:
136:
463:"How Insilico Medicine Uses AI To Accelerate Drug Development"
93:
1129:
Google Scholar page of Alex Zhavoronkov, by publication date
306:
Moskalev, Alexey; Stambler, Ilia; Zhavoronkov, Alex (2023),
1036:
305:
51:
792:
604:"Race for first drug discovered by AI nears key milestone"
1209:
253:
In 2016, Zhavoronkov was the chief science officer for
188:. In the mid 2010s, he was an adjunct professor at the
1011:"Harvesting Clones to Live Forever Would Be Monstrous"
858:
265:
In 2022, Zhavoronkov was an author of a paper titled
163:
147:, and aging economics. He is the founder and CEO of
248:
172:, Zhavoronkov received two bachelor's degrees from
915:
377:(2020), DOI: 10.26434/chemrxiv.12301457.v1 (note:
1216:
1168:"Interview with Aging Expert – Alex Zhavoronkov"
650:Want to live to 150? The world needs more humans
576:Tan, Dawn; Baker, Jalelah Abu (4 January 2023).
1156:. 9 September 2013. Event occurs at 1:45–5:20.
980:
978:
480:
478:
642:
526:
308:Artificial Intelligence for Healthy Longevity
1154:"CBS Radio with Dan Raviv in Washington, DC"
694:Cutting-edge science seeks treatment for age
688:
686:
453:
451:
449:
430:: CS1 maint: multiple names: authors list (
184:, and a PhD in physics and mathematics from
975:
597:
595:
593:
591:
532:
475:
340:
321:
854:
852:
850:
848:
519:Genetic Engineering and Biotechnology News
199:
190:Moscow Institute of Physics and Technology
31:
1079:
828:
818:
710:
708:
706:
683:
670:
601:
569:
446:
220:technology for managing human life data.
1160:
1146:
1141:PubMed Bibliography of Alex Zhavoronkov
1109:
588:
575:
16:Latvian-born AI and longevity researcher
1075:
1073:
1050:
966:
895:"Insilico Medicine raises $ 10 million"
872:. Simon and Schuster. pp. 556–57.
845:
242:generated without cognitive functions.
1217:
1210:The Biogerontology Research Foundation
1134:
1103:
1080:Berenbaum, May R. (22 November 2023).
913:
755:. Buck Institute for Research on Aging
714:
703:
666:
664:
602:Matsuyama, Kanoko (14 November 2023).
508:
506:
504:
502:
139:-born scientist and author working in
1240:Queen's University at Kingston alumni
1029:
1005:
967:Haskins, Caroline (6 December 2017).
914:Thomas, Uduak Grace (28 March 2014).
892:
484:
457:
1070:
1051:Pearson, Jordan (5 September 2016).
1044:
984:
727:
194:Buck Institute for Research on Aging
118:, Biogerontology Research Foundation
661:
499:
13:
715:Brazil, Rachel (7 December 2017).
14:
1261:
1182:
1110:Regalado, Antonio (23 May 2024).
893:Gantz, Sarah (23 February 2017).
671:Scheffler, Daniel (9 July 2013).
410:10.1021/acs.molpharmaceut.5b00982
392:37 (9) (2019), p. 1038-1040.
164:Early life, education, and career
249:Other AI and internet activities
1230:Johns Hopkins University alumni
1122:
1023:
999:
960:
942:
924:
907:
886:
786:
767:
745:
287:
1235:Moscow State University alumni
1091:. Vol. 120, no. 48.
1030:Field, Hayden (29 June 2023).
920:– via www.genomeweb.com.
64:Queen's University at Kingston
1:
1189:Editor biography at Frontiers
485:Smyth, Jamie (26 June 2023).
439:
820:10.1371/journal.pone.0020674
675:. Edge Media. Archived from
158:
7:
753:"A rather disruptive bunch"
700:(February 6, 2021), p. As5.
658:(April 2, 2023), p. K1, K5.
10:
1266:
985:Liao, Rita (6 June 2022).
384:Zhavoronkov, A., et al., "
369:Zhavoronkov, A., et al., "
341:Zhavoronkov, Alex (2012),
322:Zhavoronkov, Alex (2013).
866:; Hariri, Robert (2022).
773:
122:
111:
89:
82:
74:
59:
46:
30:
23:
1082:"Welcome, AI overlords?"
182:Johns Hopkins University
68:Johns Hopkins University
1097:10.1073/pnas.2318980120
775:US patent 8442626B2
398:Molecular Pharmaceutics
259:artificial intelligence
200:AI and medical research
186:Moscow State University
106:artificial intelligence
1250:Russian transhumanists
347:RE/Search Publications
133:Aleksandrs Zavoronkovs
1116:MIT Technology Review
698:Toronto National Post
145:regenerative medicine
98:regenerative medicine
1200:ResearchGate profile
679:on 3 September 2014.
535:Nature Biotechnology
390:Nature Biotechnology
41:meeting in June 2024
1009:(8 February 2023).
864:Diamandis, Peter H.
811:2011PLoSO...620674B
547:10.1038/nbt0717-604
461:(9 November 2022).
178:graphics processing
956:. 7 December 2017.
741:. 9 February 2017.
174:Queen's University
1245:Biogerontologists
1174:. 20 August 2013.
900:The Baltimore Sun
648:Raiany Romanni, "
379:multiple versions
284:on social media.
149:Insilico Medicine
126:
125:
116:Insilico Medicine
84:Scientific career
1257:
1176:
1175:
1164:
1158:
1157:
1150:
1144:
1138:
1132:
1126:
1120:
1119:
1107:
1101:
1100:
1077:
1068:
1067:
1065:
1063:
1048:
1042:
1041:
1027:
1021:
1020:
1007:Smith, Wesley J.
1003:
997:
996:
982:
973:
972:
964:
958:
957:
946:
940:
939:
928:
922:
921:
919:
911:
905:
904:
890:
884:
883:
856:
843:
842:
832:
822:
790:
784:
783:
782:
778:
771:
765:
764:
762:
760:
749:
743:
742:
731:
725:
724:
712:
701:
692:Tom Blackwell, "
690:
681:
680:
668:
659:
655:The Boston Globe
646:
640:
639:
637:
635:
630:. 14 August 2017
620:
614:
613:
599:
586:
585:
573:
567:
566:
530:
524:
523:
510:
497:
496:
482:
473:
472:
455:
435:
429:
421:
404:(5): 1445–1454.
359:
337:
318:
176:, and worked in
129:Alex Zhavoronkov
102:drug development
35:
25:Alex Zhavoronkov
21:
20:
1265:
1264:
1260:
1259:
1258:
1256:
1255:
1254:
1215:
1214:
1185:
1180:
1179:
1172:Book Tour Radio
1166:
1165:
1161:
1152:
1151:
1147:
1139:
1135:
1127:
1123:
1108:
1104:
1078:
1071:
1061:
1059:
1049:
1045:
1028:
1024:
1016:National Review
1004:
1000:
983:
976:
965:
961:
948:
947:
943:
930:
929:
925:
912:
908:
891:
887:
880:
857:
846:
791:
787:
780:
772:
768:
758:
756:
751:
750:
746:
733:
732:
728:
713:
704:
691:
684:
669:
662:
647:
643:
633:
631:
628:Bioengineer.org
622:
621:
617:
609:The Japan Times
600:
589:
574:
570:
531:
527:
522:. 20 June 2023.
512:
511:
500:
492:Financial Times
483:
476:
468:Forbes Magazine
456:
447:
442:
423:
422:
357:
334:
290:
278:head transplant
251:
235:National Review
230:Wesley J. Smith
210:Peter Diamandis
202:
166:
161:
66:
60:Alma mater
55:
42:
26:
17:
12:
11:
5:
1263:
1253:
1252:
1247:
1242:
1237:
1232:
1227:
1213:
1212:
1207:
1202:
1197:
1196:, at 1:44-5:10
1191:
1184:
1183:External links
1181:
1178:
1177:
1159:
1145:
1133:
1121:
1102:
1069:
1043:
1022:
998:
974:
959:
941:
923:
906:
885:
879:978-1982121709
878:
844:
785:
766:
744:
726:
702:
682:
660:
641:
615:
587:
568:
525:
498:
474:
444:
443:
441:
438:
437:
436:
393:
382:
366:
365:
361:
360:
356:978-1889307350
355:
338:
333:978-0230342200
332:
319:
302:
301:
289:
286:
250:
247:
232:, writing for
201:
198:
165:
162:
160:
157:
124:
123:
120:
119:
113:
109:
108:
91:
87:
86:
80:
79:
76:
75:Known for
72:
71:
61:
57:
56:
50:
48:
44:
43:
36:
28:
27:
24:
15:
9:
6:
4:
3:
2:
1262:
1251:
1248:
1246:
1243:
1241:
1238:
1236:
1233:
1231:
1228:
1226:
1225:Living people
1223:
1222:
1220:
1211:
1208:
1206:
1203:
1201:
1198:
1195:
1192:
1190:
1187:
1186:
1173:
1169:
1163:
1155:
1149:
1142:
1137:
1130:
1125:
1117:
1113:
1106:
1098:
1094:
1090:
1088:
1083:
1076:
1074:
1058:
1054:
1047:
1039:
1038:
1033:
1026:
1018:
1017:
1012:
1008:
1002:
994:
993:
988:
981:
979:
970:
963:
955:
951:
945:
937:
933:
927:
918:
910:
902:
901:
896:
889:
881:
875:
871:
870:
865:
861:
860:Robbins, Tony
855:
853:
851:
849:
840:
836:
831:
826:
821:
816:
812:
808:
805:(6): e20674.
804:
800:
796:
789:
776:
770:
754:
748:
740:
736:
730:
722:
718:
711:
709:
707:
699:
695:
689:
687:
678:
674:
667:
665:
657:
656:
651:
645:
629:
625:
619:
611:
610:
605:
598:
596:
594:
592:
583:
579:
572:
564:
560:
556:
552:
548:
544:
540:
536:
529:
521:
520:
515:
509:
507:
505:
503:
494:
493:
488:
481:
479:
470:
469:
464:
460:
454:
452:
450:
445:
433:
427:
419:
415:
411:
407:
403:
399:
394:
391:
387:
383:
380:
376:
372:
368:
367:
363:
362:
358:
352:
348:
344:
339:
335:
329:
326:. Macmillan.
325:
320:
317:
313:
309:
304:
303:
299:
298:
297:
295:
285:
283:
279:
274:
272:
268:
263:
260:
256:
246:
243:
241:
237:
236:
231:
227:
221:
219:
214:
211:
207:
197:
195:
191:
187:
183:
179:
175:
171:
156:
154:
150:
146:
142:
141:biotechnology
138:
134:
130:
121:
117:
114:
110:
107:
103:
99:
95:
92:
88:
85:
81:
77:
73:
69:
65:
62:
58:
53:
49:
45:
40:
34:
29:
22:
19:
1171:
1162:
1148:
1136:
1124:
1115:
1105:
1085:
1060:. Retrieved
1056:
1046:
1035:
1025:
1014:
1001:
990:
962:
953:
944:
935:
926:
909:
898:
888:
868:
802:
798:
788:
769:
757:. Retrieved
747:
738:
729:
720:
697:
677:the original
653:
644:
632:. Retrieved
627:
618:
607:
571:
538:
534:
528:
517:
490:
466:
459:Chace, Calum
426:cite journal
401:
397:
389:
374:
342:
323:
310:, Springer,
307:
291:
288:Publications
275:
266:
264:
252:
244:
240:human clones
233:
222:
215:
206:Tony Robbins
203:
167:
152:
132:
128:
127:
112:Institutions
83:
18:
1057:Motherboard
634:28 November
282:viral video
226:Calum Chace
1219:Categories
1062:17 January
992:TechCrunch
869:Life Force
541:(7): 605.
440:References
316:B0C6CS2XJ3
218:blockchain
1143:, Pubmed.
936:old.sk.ru
739:MIPT News
563:205269847
255:Beauty.AI
159:Biography
1205:ORCID ID
839:21695206
799:PLOS ONE
555:28700560
418:27007977
375:ChemRxiv
364:Articles
168:Born in
54:, Latvia
954:Inverse
830:3112189
807:Bibcode
759:23 June
271:ChatGPT
137:Latvian
135:) is a
1089:(PNAS)
876:
837:
827:
781:
561:
553:
416:
353:
330:
314:
294:PubMed
170:Latvia
131:(born
90:Fields
559:S2CID
300:Books
257:, an
94:aging
70:(JHU)
37:At a
1064:2017
1037:CNBC
874:ISBN
835:PMID
761:2024
636:2017
551:PMID
432:link
414:PMID
351:ISBN
328:ISBN
312:ASIN
208:and
52:Riga
47:Born
1093:doi
825:PMC
815:doi
696:",
652:",
582:CNA
543:doi
406:doi
388:",
373:",
39:WEF
1221::
1170:.
1114:.
1084:.
1072:^
1055:.
1034:.
1013:.
989:.
977:^
952:.
934:.
897:.
862:;
847:^
833:.
823:.
813:.
801:.
797:.
737:.
719:.
705:^
685:^
663:^
626:.
606:.
590:^
580:.
557:.
549:.
539:35
537:.
516:.
501:^
489:.
477:^
465:.
448:^
428:}}
424:{{
412:.
402:13
400:.
381:).
349:,
345:,
296:.
155:.
143:,
104:,
100:,
96:,
1131:.
1118:.
1099:.
1095::
1066:.
1040:.
1019:.
995:.
971:.
938:.
903:.
882:.
841:.
817::
809::
803:6
763:.
723:.
638:.
612:.
584:.
565:.
545::
495:.
471:.
434:)
420:.
408::
336:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
